PAOG Announces CBD Pet Product Line To Launch In December

Rhea-AI Summary

PAO Group, Inc. (OTC Pink: PAOG) has announced plans to launch a CBD pet product line in December, capitalizing on the estimated $100 billion pet products market. The company, which holds intellectual property linked to its proprietary CBD extraction method (U.S. Patent No. 9,199,960), is also developing CBD nutraceuticals for humans. PAOG has confirmed shipping its initial products to North American Cannabis Holdings for online sales, anticipating revenue growth from these launches as it prepares additional follow-on products.

Positive

• Plans to launch CBD pet product line in December.
• Intellectual property linked to a patented CBD extraction method.
• Confirmed shipping of CBD nutraceuticals to distribution partner.
• Anticipated revenue generation starting Q4 2021.

Negative

• None.

Sandusky, OH, Nov. 01, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company has finalized plans to launch its CBD pet product line in December.

The pet products market is estimated at over $100 billion per year.

Last year, the company acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). PAOG is developing both pharmaceutical and nutraceutical treatments for humans based on this intellectual property. Today, for the first time, the company revealed it is also developing CBD products for pets.

PAOG recently announced the launch of its first two CBD nutraceutical products, RelaxRX CBD, a sleep aid, and RehabRX CBD, a salve.

PAOG is on track to realize its first revenue this year, starting in Q4 2021, since acquiring the extraction technology.

PAOG has confirmed shipping its first and second CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (OTC Pink: USMJ). The product will soon be for sale online at www.USMJ.com.

PAOG expects revenue to grow rapidly following its first and second CBD nutraceutical product launches as the company has follow-on products lined up to follow these products, adding to overall sales potential.

Learn more about USMJ’s ecommerce site at www.usmj.com.

Learn more about PAOG at www.paogroupinc.com.

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

CONTACT INFORMATION
Contact Us:
Jim DiPrima
(888) 979-2675
info@pao.group

FAQ

When is PAOG launching its CBD pet product line?

PAOG is launching its CBD pet product line in December.

What is the estimated market size for pet products?

The pet products market is estimated to exceed $100 billion per year.

What patent does PAOG hold for CBD extraction?

PAOG holds U.S. Patent No. 9,199,960 for its CBD extraction method.

When does PAOG expect to generate revenue?

PAOG expects to realize its first revenue in Q4 2021.

Who is PAOG's distribution partner for its CBD products?

PAOG's distribution partner is North American Cannabis Holdings, Inc. (OTC Pink: USMJ).